Kane Biotech Inc. (TSXV:KNE)
Canada
· Delayed Price · Currency is CAD 0.0750
-0.0050 (-6.25%)
May 12, 2025, 10:47 AM EDT
Kane Biotech Revenue
Kane Biotech had revenue of 1.28M CAD in the quarter ending September 30, 2024, with 4,650.21% growth. This brings the company's revenue in the last twelve months to 2.01M, down -216.43% year-over-year. In the year 2023, Kane Biotech had annual revenue of 148.98K, down -4.95%.
Revenue (ttm)
2.01M
Revenue Growth
-216.43%
P/S Ratio
6.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 148.98K | -7.75K | -4.95% |
| Dec 31, 2022 | 156.73K | -1.45M | -90.25% |
| Dec 31, 2021 | 1.61M | 266.20K | 19.84% |
| Dec 31, 2020 | 1.34M | -351.95K | -20.78% |
| Dec 31, 2019 | 1.69M | 1.19M | 234.51% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 896.45M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 179.08M |
| WELL Health Technologies | 919.69M |
| Curaleaf Holdings | 1.89B |
Kane Biotech News
- 6 days ago - Philip Renaud files Early Warning Report in respect of Kane Biotech Inc. - Benzinga
- 7 days ago - Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company - GlobeNewsWire
- 14 days ago - Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change - Benzinga
- 14 days ago - Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change - GlobeNewsWire
- 4 weeks ago - Kane Biotech Announces New Agreement with Outside the Box Capital Inc. - GlobeNewsWire
- 2 months ago - Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial - GlobeNewsWire
- 2 months ago - Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel - GlobeNewsWire
- 2 months ago - Kane Biotech Announces Second and Final Closing of Private Placement Offering - GlobeNewsWire